PLANO, Texas--(BUSINESS WIRE)--VuCOMP, Inc. today announced an agreement with Konica Minolta Medical Imaging to include VuCOMP’s M-Vu CAD, the first mammography CAD product clinically proven in a pivotal reader study, as companion technology for Konica Minolta’s high resolution REGIUS Mammography systems. The agreement provides VuCOMP the ability to market its advanced CAD system through Konica Minolta’s U.S. distribution network.
“VuCOMP’s CAD performs extremely well with Konica Minolta’s REGIUS Mammography systems, making reading rapid and reliable,” said Konica Minolta’s Digital Radiography Products Marketing Manager Darren Werner. “The M-Vu CAD system has been validated in a major reader study which demonstrated a high quality product, and we’re very pleased to be able to offer our customers this combination of two of the most advanced systems available for mammography.”
Jeff Wehnes, President and CEO of VuCOMP, said, “We are delighted to offer our M-Vu CAD system as part of Konica Minolta’s mammography product line. This brings us another step closer to our goal of becoming the world’s leading provider of CAD products, helping radiologists provide the best possible care to women.”
While mammography CAD systems have been FDA-approved since 1998, FDA guidelines now recommend comprehensive reader studies demonstrating that radiologists are more effective using the CAD. M-Vu CAD is the first product to meet this FDA standard for proving effectiveness, receiving FDA approval for digital mammography in October, 2012.
About Konica Minolta Medical Imaging
Konica Minolta Medical Imaging is a world-class provider and market leader in medical diagnostic primary imaging. With over 75 years of innovation, Konica Minolta is globally recognized as a leader that provides cutting-edge technologies and comprehensive support aimed at providing real solutions to meet customers’ needs. Konica Minolta Medical Imaging, headquartered in Wayne, NJ, is a unit of Konica Minolta, Inc. For more information on Konica Minolta Medical Imaging products and services, please visit www.medical.konicaminolta.us.
About VuCOMP, Inc.
VuCOMP, Inc. leads the way in setting a new standard for CAD. The company is dedicated exclusively to developing advanced cancer detecting technologies. VuCOMP’s engineering team has worked together since 1986, pioneering some of the world’s most advanced computer vision systems. For more information, please visit www.vucomp.com.